• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patients.

作者信息

Storck Tatum N, Morsink Linde M, Biswana Anouschka, Hazenberg Carin L E, Huls Gerwin, Choi Goda

机构信息

Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands; University of Groningen, Groningen, The Netherlands.

出版信息

Bone Marrow Transplant. 2025 May;60(5):737-739. doi: 10.1038/s41409-025-02552-y. Epub 2025 Mar 19.

DOI:10.1038/s41409-025-02552-y
PMID:40108437
Abstract
摘要

相似文献

1
Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patients.急性髓系白血病患者接受 HLA 全相合造血干细胞移植并使用移植后环磷酰胺后进行供体淋巴细胞输注。
Bone Marrow Transplant. 2025 May;60(5):737-739. doi: 10.1038/s41409-025-02552-y. Epub 2025 Mar 19.
2
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.急性髓系白血病中，与单倍体相合供体移植相比，HLA全相合供体移植后使用环磷酰胺：一项代表GETH-TC开展的研究
Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31.
3
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.异基因造血干细胞移植联合脐带血与移植后环磷酰胺治疗急性髓系白血病的非匹配无关供者。
J Hematol Oncol. 2021 May 3;14(1):76. doi: 10.1186/s13045-021-01086-2.
4
Prophylactic donor lymphocyte infusion after haploidentical hematopoietic cell transplantation and post-transplant cyclophosphamide for treatment of high-risk myeloid neoplasms in children: A retrospective study.亲缘单倍体造血细胞移植后预防性供者淋巴细胞输注和移植后环磷酰胺治疗儿童高危髓系肿瘤：一项回顾性研究。
Pediatr Blood Cancer. 2023 Nov;70(11):e30659. doi: 10.1002/pbc.30659. Epub 2023 Sep 5.
5
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.同种异体造血干细胞移植治疗 HLA 相合同胞供者来源的急性髓系白血病患者中，移植后环磷酰胺与抗胸腺细胞球蛋白的比较：来自欧洲血液和骨髓移植学会急性白血病工作组的回顾性分析。
Cancer. 2021 Jan 15;127(2):209-218. doi: 10.1002/cncr.33255. Epub 2020 Oct 29.
6
T Cell-Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor Transplantation.采用移植后环磷酰胺的T细胞充足的HLA单倍型相合供体移植是HLA匹配的亲属或匹配的无关供体移植后复发患者的一种有效挽救治疗方法。
Biol Blood Marrow Transplant. 2016 Oct;22(10):1861-1866. doi: 10.1016/j.bbmt.2016.06.026. Epub 2016 Jun 29.
7
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.老年急性髓系白血病或骨髓增生异常综合征患者采用亲缘单倍体造血干细胞移植联合移植后环磷酰胺和外周血造血干细胞移植。
Biol Blood Marrow Transplant. 2017 Oct;23(10):1736-1743. doi: 10.1016/j.bbmt.2017.06.019. Epub 2017 Jul 5.
8
Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML).急性髓系白血病患者 T 细胞完全清除的单倍体相合骨髓移植后 KIR/HLA 关系及其他临床变量的研究。
BMC Immunol. 2023 Jun 20;24(1):10. doi: 10.1186/s12865-023-00548-1.
9
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors.在接受 10/10 HLA 匹配的无关供体异基因干细胞移植的处于首次完全缓解的急性髓系白血病患者中，移植后环磷酰胺与抗胸腺细胞球蛋白的比较。
J Hematol Oncol. 2020 Jul 3;13(1):87. doi: 10.1186/s13045-020-00923-0.
10
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.体内T细胞清除对采用氟达拉滨-静脉白消安清髓方案预处理的首次完全缓解期急性髓系白血病患者进行HLA全相合异基因干细胞移植的影响：欧洲血液与骨髓移植协会急性白血病工作组报告
J Hematol Oncol. 2017 Jan 24;10(1):31. doi: 10.1186/s13045-016-0389-4.

本文引用的文献

1
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.移植后微小残留病和 T 细胞嵌合状态可预测接受 AML/MDS 同种异体移植物的患者的结局。
Blood Adv. 2023 Jul 25;7(14):3666-3676. doi: 10.1182/bloodadvances.2022009493.
2
Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment.异基因造血干细胞移植后急性髓系白血病的复发：预防和治疗概述。
Int J Hematol. 2022 Sep;116(3):330-340. doi: 10.1007/s12185-022-03416-7. Epub 2022 Jul 16.
3
Treatment of Relapsed Acute Myeloid Leukemia.
复发急性髓系白血病的治疗。
Curr Treat Options Oncol. 2020 Jun 29;21(8):66. doi: 10.1007/s11864-020-00765-5.
4
Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation.地西他滨联合供体淋巴细胞输注可使异基因造血细胞移植后白血病负荷较高的复发髓系恶性肿瘤患者获得缓解。
Leuk Res. 2018 Sep;72:20-26. doi: 10.1016/j.leukres.2018.07.005. Epub 2018 Jul 7.
5
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.主要组织相容性复合体（MHC）和非 MHC 供体/受者遗传差异对异基因造血细胞移植结局的影响。
Blood. 2012 Oct 4;120(14):2796-806. doi: 10.1182/blood-2012-04-347286. Epub 2012 Aug 2.
6
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.供体淋巴细胞输注治疗成人急性髓系白血病异基因干细胞移植后首次血液学复发：EBMT急性白血病工作组的回顾性危险因素分析及与其他策略的比较
J Clin Oncol. 2007 Nov 1;25(31):4938-45. doi: 10.1200/JCO.2007.11.6053. Epub 2007 Oct 1.